Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 5, 2009, Pages 487-495

  Smith, Ian M ^a   Mithani, Suhail K ^a   Liu, Chunyan ^a   Chang, Steven S ^a   Begum, Shahnaz ^a   Dhara, Mousiumi ^a   Westra, William ^a   Sidranksy, David ^a   Califano, Joseph A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX1T1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENETICS; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DLEC1 GENE; DNA EXTRACTION; DNA MICROARRAY; GENE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; REAL TIME POLYMERASE CHAIN REACTION; RFC4 GENE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UPREGULATION; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HEAD AND NECK TUMOR;

CARCINOMA, SQUAMOUS CELL; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 66149171755     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.43     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106-130.
2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098. (Pubitemid 37464533)
3. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114(5):806-816. (Pubitemid 40344442)
4. Kim MM, Califano JA. Molecular pathology of head-and-neck cancer. Int J Cancer. 2004;112(4):545-553. (Pubitemid 39425933)
5. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci U S A. 1993;90(23):10914-10921.
6. Stark GR, Wahl GM. Gene amplification. Annu Rev Biochem. 1984;53:447-491. (Pubitemid 14059147)
7. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet. 2003;34(4):369-376. (Pubitemid 36935328)
8. Nogueira CP, Dolan RW, Gooey J, et al. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope. 1998;108(3):345-350. (Pubitemid 28136640)
9. Singh B, Stoffel A, Gogineni S, et al. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol. 2002;161(2):365-371. (Pubitemid 36142144)
10. Sorrells DL, Ghali GE, Meschonat C, et al. Competitive PCR to detect eIF4E gene amplification in head and neck cancer. Head Neck. 1999;21(1):60-65. (Pubitemid 29006457)
11. Wang MB, Alavi S, Engstrom M, et al. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anti-cancer Res. 1999;19(2A):925-931. (Pubitemid 29257518)
12. Weichselbaum RR, Dunphy EJ, Beckett MA, et al. Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines. Head Neck. 1989;11(5):437-442. (Pubitemid 19210525)
13. Sabbir MG, Roy A, Mandal S, Dam A, Roychoudhury S, Panda CK. Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour. Int J Exp Pathol. 2006;87(2):151-161.
14. Maestro R, Dolcetti R. Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas [in Italian]. Acta Otorhinolaryngol Ital. 1996;16(3)(suppl 54):21-26.
15. Collins FS, Barker AD. Mapping the cancer genome: pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am. 2007;296(3):50-57.
16. Strauss BS. Limits to the Human Cancer Genome Project? Science. 2007;315(5813):762-764. (Pubitemid 46255802)
17. Sjöblom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314(5797):268-274. (Pubitemid 44571966)
18. Garraway LA, Weir BA, Zhao X, et al. "Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol. 2005;70:25-34. (Pubitemid 44124854)
19. Garraway LA, Widlund HR, Rubin MA, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436(7047):117-122. (Pubitemid 40966196)
20. Chen W, Salto-Tellez M, Palanisamy N, et al. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer. 2007;46(3):288-301. (Pubitemid 46155323)
21. Pujana MA, Ruiz A, Badenas C, et al. Molecular characterization of a t(9;12)(p21; q13) balanced chromosome translocation in combination with integrative genomics analysis identifies C9orf14 as a candidate tumor-suppressor. Genes Chromosomes Cancer. 2007;46(2):155-162. (Pubitemid 44913380)
22. Wang Q, Diskin S, Rappaport E, et al. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 2006;66(12):6050-6062.
23. Dahia PL, Hao K, Rogus J, et al; Familial Pheochromocytoma Consortium. Novel pheochromocytoma susceptibility loci identified by integrative genomics. Cancer Res. 2005;65(21):9651-9658.
24. Peterson LF, Boyapati A, Ahn EY, et al. Acute myeloid leukemia with the 8q22; 21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. Blood. 2007;110(3):799-805. (Pubitemid 47267414)
25. Johnson A, Yao NY, Bowman GD, Kuriyan J, O'Donnell M. The replication factor C clamp loader requires arginine finger sensors to drive DNA binding and proliferating cell nuclear antigen loading. J Biol Chem. 2006;281(46):35531- 35543. (Pubitemid 46036588)
26. Narayan G, Bourdon V, Chaganti S, et al. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer. 2007;46(4):373-384. (Pubitemid 46411328)
27. Slebos RJ, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12(3, pt 1):701-709. (Pubitemid 43259848)
28. Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y. Isolation and mutational analysis of a novel human cDNA, DEC1 (Deleted in Esophageal Cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer. 2000;27(2):169-176. (Pubitemid 30030315)
29. Kwong J, Chow LS, Wong AY, et al. Epigenetic inactivation of the Deleted in Lung and Esophageal Cancer 1 gene in nasopharyngeal carcinoma. Genes Chromosomes Cancer. 2007;46(2):171-180. (Pubitemid 44913382)
30. Sparano A, Quesnelle KM, Kumar MS, et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope. 2006;116(5):735-741. (Pubitemid 44318029)
31. Ogino S, Kawasaki T, Ogawa A, Kirkner GJ, Loda M, Fuchs CS. TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instabilityhigh colorectal cancer. Hum Pathol. 2007;38(4):614-620. (Pubitemid 46399889)
32. Muñoz NM, Upton M, Rojas A, et al. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation. Cancer Res. 2006;66(20):9837-9844. (Pubitemid 44672034)
33. Biswas S, Chytil A, Washington K, et al. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res. 2004;64(14):4687-4692. (Pubitemid 38924506)
34. Kirkpatrick H, Waber P, Hoa-Thai T, et al. Infrequency of BRCA2 alterations in head and neck squamous cell carcinoma. Oncogene. 1997;14(18):2189-2193. (Pubitemid 27248230)
35. Nawroz-Danish HM, Koch WM, Westra WH, Yoo G, Sidransky D. Lack of BRCA2 alterations in primary head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 1998;119(1):21-25. (Pubitemid 28350660)
36. Yan M, Kanbe E, Peterson LF, et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med. 2006;12(8):945-949. (Pubitemid 44175147)
37. Stransky N, Vallot C, Reyal F, et al. Regional copy number-independent deregulation of transcription in cancer. Nat Genet. 2006;38(12):1386-1396. (Pubitemid 44837560)
38. Kwong J, Lee JY, Wong KK, et al. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer. Neoplasia. 2006;8(4):268-278.
39. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res. 1999;59(8):1966-1972. (Pubitemid 29186173)